Dipyrone for acute primary headaches
a Systematic Review
DOI:
https://doi.org/10.34024/rnc.2007.v15.8708Keywords:
Review, Dipyrone, HeadacheAbstract
UMMARY Introduction: Headaches commonly affect working-age people. Dipyrone is largely used in many countries. Objectives: To determine effectiveness/safety of dipyrone for adults with acute primary headaches. Method: Double blind randomized controlled trials systematic review. Dichotomous data were expressed as relative risks and risk differences, and continuous data as weighted mean differences. If possible, numbers-needed-to-treat were calculated. Results: Four studies were included (636 subjects). Meta-analysis was possible for one outcome, favouring dipyrone. Regarding episodic tension-type headache and migraine, individual studies data showed dipyrone statistically significant beneficial effect. No severe adverse events were reported. There was no statistically significant difference between dipyrone and placebo regarding mild to moderate adverse events. Conclusion: Dipyrone is effective in migraine and episodic tension-type headache. Conclusions about its safety and agranulocytosis can not be drawn probably due to the relatively small sample. If the results of a recent study, which is related to the incidence of agranulocytosis in Latin America, do not clarify the question, data from observational studies on dipyrone side effects should be searched to determine its safety
References
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267(1):64-69. DOI: https://doi.org/10.1001/jama.1992.03480010072027
Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;279(5):381-383. DOI: https://doi.org/10.1001/jama.279.5.381
Finkel AG. Epidemiology of cluster headache. Cur Pain Headache Rep 2003;7(2):144-149. DOI: https://doi.org/10.1007/s11916-003-0025-1
Lipton RB, Stewart WF, Von Korff M. The burden of migraine. A review of cost to society. Pharmacoeconomics 1994;6(3):215-221. DOI: https://doi.org/10.2165/00019053-199406030-00005
Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson, RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992;19(3): 333-339. DOI: https://doi.org/10.1017/S0317167100041950
Solomon GD, Price KL. Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics 1997;11 (Suppl 1):1-10. DOI: https://doi.org/10.2165/00019053-199700111-00003
Edwards JE, Meseguer F, Faura CC, Moore RA, McQuay HJ. Single dose dipyrone for acute postoperative pain. In: The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD003227. DOI: 10.1002/14651858. CD003227
Fendrich Z. Metamizol - nové úcinné analgetikum s dlouhou historií. Prehled farmakologie a praktického vyuzití [Metamizol - a new effective analgesic with a long history. Overview of its pharmacology and clinical use]. Cas Lek Cesk 2000;139(14):440-444.
Edwards JE, Meseguer F, Faura C, Moore RA, McQuay HJ. Single dose dipyrone for acute renal colic pain. In: The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003867. DOI: 10.1002/14651858. CD003867. DOI: https://doi.org/10.1002/14651858
Edwards JE, McQuay HJ. Dipyrone and agranulocytosis: what is the risk? Lancet 2002;360(9344):1438 DOI: https://doi.org/10.1016/S0140-6736(02)11489-9
The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986;256(13):1749-1757. DOI: https://doi.org/10.1001/jama.1986.03380130077032
Bäckström M, Hägg S, Mjörndal T, Dahlqvist R. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiol Drug Safe 2002;11(3):239-245. DOI: https://doi.org/10.1002/pds.697
Selection bias (website). Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 Section 6.3. (updated 05/2005; accessed 07/2006). Available in: http://www.cochrane.org/resources/handbook/hbook.htm
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Contr Clin Trials 1996;17(1):1-12 DOI: https://doi.org/10.1016/0197-2456(95)00134-4
Intention-to-treat issues (website). Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 Section 8.4. (updated 05/2005, accessed 07/2006). Available in http://www.cochrane.org/resources/handbook/hbook.htm
McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200. DOI: https://doi.org/10.1136/bmj.313.7066.1200
Cochrane Collaboration open learning material for reviewers 1.1 (website) Alderson P, Green S (eds) (updated 11/2002; accessed 08/06/2006). Available in: http://www.cochrane-net.org/openlearning/
Classen W. Placebo application, personality, and headaches: a signal detection theory analysis of experimentally induced pain in comparison to clinical pain. Pharmacopsychiatry 1984;17(3):98-101. DOI: https://doi.org/10.1055/s-2007-1017416
Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study. Cephalalgia 2001;21(2):90-95. DOI: https://doi.org/10.1046/j.1468-2982.2001.00143.x
Hackenthal E. Paracetamol and Metamizol in der Therapie chronischer Schmerzen [Paracetamol and metamizol in the treatment of chronic pain syndromes]. Schmerz 1997;11(4):269-275. DOI: https://doi.org/10.1007/s004820050097
Lujan M, Lopez-Fiesco A, Lopez y Martinez E, Zamora Lopez G, Alvarez RM. Experimental tension headache in humans: a double blind comparison of the analgesic effect of dipyrone, naproxen plus paracetamol or placebo. Proc West Pharmacol Soc 1992;35:201-205.
Martinez-Martin P, Raffaelli E Jr., Titus F, Despuig J, Fragoso YD, DiezTejedor E, et al. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001;21(5):604-610. DOI: https://doi.org/10.1046/j.1468-2982.2001.00216.x
Bigal ME, Bordini CA, Speciali JG. Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study. Braz J Med Bio Res 2002;35(10):1139-1145. DOI: https://doi.org/10.1590/S0100-879X2002001000005
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache 2002;42(9):862-871. DOI: https://doi.org/10.1046/j.1526-4610.2002.02204.x
Bigal ME, Bordini CA, Speciali JG. Eficácia de três drogas sobre a aura migranosa: um estudo randomizado placebo controlado [Efficacy of three drugs in the treatment of migrainous aura: a randomized placebo-controlled study]. Arq Neuropsiquiatr 2002;60(2-B):406-409. DOI: https://doi.org/10.1590/S0004-282X2002000300013
Hamerschlak N, Maluf E, Pasquini R Eluf-Neto J, Moreira FR, Cavalcanti AB, et al. Incidence of aplastic anemia and agranulocytosis in Latin America: the LATIN study. Sao Paulo Med J 2005;123(3): 101-104. DOI: https://doi.org/10.1590/S1516-31802005000300002
